12th International Symposium on Myelodysplastic Syndromes
May 8-11, 2013 Berlin, Germany
The scientific program is designed to meet the aims of The MDS Foundation, which are “to provide an ongoing exchange of information relating to MDS and provides patients with referrals to Centers of Excellence, contact names for available clinical trials, sharing of new research and treatment options between physicians, and extension of educational support to both physicians and patients." The format will include plenary sessions (including a nursing symposium), debates, case-based discussion, topical workshops, oral and poster presentations.
This 12th symposium will again promote the clinical application of existing knowledge and the acquisition of new knowledge by bringing together clinicians, scientists and educators from around the world who deal with MDS.
Clinical Management: General
Diagnosis (including morphology, flow cytometry, molecular)
Epidemiology (including demographics, quality of life, co-morbidity)
Pathogenesis (including molecular, immunological, cellular, animal models, other)
Childhood MDS
Prognostic Factors and Models
Supportive Care including Iron Chelation Therapy
Stem Cell Transplantation
Therapy (including high-risk MDS, low-risk MDS, other)
Other
